DuCLOX-2/5 Inhibition Attenuates Inflammatory Response and Induces Mitochondrial Apoptosis for Mammary Gland Chemoprevention
The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibi...
Saved in:
Published in | Frontiers in pharmacology Vol. 9; p. 314 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
06.04.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through
H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments. |
---|---|
AbstractList | The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through
1
H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments. The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through 1H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments. The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments. The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through 1H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments.The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. The monotherapy and combination therapy of zaltoprofen (COX-2 inhibitor) and zileuton (5-LOX inhibitor) were validated for their effect against methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. The combination therapy demarcated significant effect upon the cellular proliferation as evidenced through decreased in alveolar bud count and restoration of the histopathological architecture when compared to toxic control. DuCLOX-2/5 inhibition also upregulated levels of caspase-3 and caspase-8, and restored oxidative stress markers (GSH, TBARs, protein carbonyl, SOD and catalase). The immunoblotting and qRT-PCR studies revealed the participation of the mitochondrial mediated death apoptosis pathway along with favorable regulation of COX-2, 5-LOX. Aforementioned combination restored the metabolic changes to normal when scrutinized through 1H NMR studies. Henceforth, the DuCLOX-2/5 inhibition was recorded to import significant anticancer effects in comparison to either of the individual treatments. |
Author | Ansari, Mohd N. Rawat, Jitendra K. Devi, Uma Saeedan, Abdulaziz S. Pandey, Rakesh Rawat, Atul K. Singh, Lakhveer Kaithwas, Gaurav Gautam, Swetlana Singh, Manjari Yadav, Rajnish K. Kumar, Dinesh Sammi, Shreesh R. Roy, Subhadeep |
AuthorAffiliation | 2 Center for Biomedical Research, Sanjay Gandhi Post Graduate Institute of Medical Sciences Campus , Lucknow , India 4 Department of Pharmaceutical Sciences, Faculty of Health and Medical Sciences, Sam Higginbottom Institute of Agricultural Sciences and Technology , Allahabad , India 1 Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University) , Lucknow , India 5 Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University , Al-Kharj , Saudi Arabia 3 Department of Microbial Technology and Nematology, CSIR-Central Institute of Medicinal and Aromatic Plants , Lucknow , India |
AuthorAffiliation_xml | – name: 3 Department of Microbial Technology and Nematology, CSIR-Central Institute of Medicinal and Aromatic Plants , Lucknow , India – name: 2 Center for Biomedical Research, Sanjay Gandhi Post Graduate Institute of Medical Sciences Campus , Lucknow , India – name: 4 Department of Pharmaceutical Sciences, Faculty of Health and Medical Sciences, Sam Higginbottom Institute of Agricultural Sciences and Technology , Allahabad , India – name: 1 Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University) , Lucknow , India – name: 5 Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University , Al-Kharj , Saudi Arabia |
Author_xml | – sequence: 1 givenname: Swetlana surname: Gautam fullname: Gautam, Swetlana – sequence: 2 givenname: Atul K. surname: Rawat fullname: Rawat, Atul K. – sequence: 3 givenname: Shreesh R. surname: Sammi fullname: Sammi, Shreesh R. – sequence: 4 givenname: Subhadeep surname: Roy fullname: Roy, Subhadeep – sequence: 5 givenname: Manjari surname: Singh fullname: Singh, Manjari – sequence: 6 givenname: Uma surname: Devi fullname: Devi, Uma – sequence: 7 givenname: Rajnish K. surname: Yadav fullname: Yadav, Rajnish K. – sequence: 8 givenname: Lakhveer surname: Singh fullname: Singh, Lakhveer – sequence: 9 givenname: Jitendra K. surname: Rawat fullname: Rawat, Jitendra K. – sequence: 10 givenname: Mohd N. surname: Ansari fullname: Ansari, Mohd N. – sequence: 11 givenname: Abdulaziz S. surname: Saeedan fullname: Saeedan, Abdulaziz S. – sequence: 12 givenname: Dinesh surname: Kumar fullname: Kumar, Dinesh – sequence: 13 givenname: Rakesh surname: Pandey fullname: Pandey, Rakesh – sequence: 14 givenname: Gaurav surname: Kaithwas fullname: Kaithwas, Gaurav |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29681851$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Ul1rFDEUDVKxtfbdJ5lHX2abj0kmeRGWVevCloIo-BYy-eikzE7GJFMQ_PFmdltpBQMh4d5zzk3uPa_ByRhGC8BbBFeEcHHppl7FFYaIryAkqHkBzhBjpBYc4ZMn91NwkdIdLIsIQVjzCpxiwTjiFJ2B3x_nze7mR40vabUde9_57MNYrXO246yyTSXqBrXfqxzir-qrTVMYk63UaErGzLogrn0Oug-jiV4N1XoKUw7Jp8qFWF0v1EK8GhbGprf7MEV7b8elzBvw0qkh2YuH8xx8__zp2-ZLvbu52m7Wu1o3DOe6g4RhQhFVFmpMu7KpQ8ogh6gzQrcWE0Mc1NpY1LaaG4yRg1xA3VIONTkH26OuCepOTtEvT5JBeXkIhHgrVcxeD1Y2ou06iKnB3DW4s5wp7KBqmMWtaPii9eGoNc3d3hpdfhLV8Ez0eWb0vbwN95Jy0TLKisD7B4EYfs42Zbn3SduhNMiGOUkMy3QIwmiBvnta62-Rx_EVADsCdAwpReuk9lktrS2l_SARlItV5MEqcrGKPFilEOE_xEft_1L-AOOdxAg |
CitedBy_id | crossref_primary_10_1002_jbt_70016 crossref_primary_10_1016_j_jgeb_2025_100480 crossref_primary_10_1002_cbf_3513 crossref_primary_10_1007_s00210_019_01658_7 crossref_primary_10_1002_jcp_27168 crossref_primary_10_1186_s12860_021_00371_9 crossref_primary_10_3389_fcell_2021_736910 crossref_primary_10_1016_j_bioorg_2022_106147 crossref_primary_10_1038_s41598_020_67420_9 crossref_primary_10_1016_j_bbadis_2020_165713 crossref_primary_10_3389_fphar_2021_788977 crossref_primary_10_1186_s12885_019_6152_9 crossref_primary_10_1177_0960327120931165 |
Cites_doi | 10.1016/j.tcb.2017.05.001 10.1016/j.physbeh.2017.10.024 10.1093/carcin/bgi012 10.1101/cshperspect.a008656 10.1093/nar/gkl923 10.1007/s10787-009-8049-8 10.1007/s12282-016-0723-2 10.1007/s10787-016-0280-5 10.1039/C7RA09689E 10.2174/2213235X04666160809123143 10.1093/glycob/cwm100 10.4172/jpb.1000111 10.1242/jcs.073643 10.1016/0016-5085(94)90246-1 10.1038/nrc3365 10.1073/pnas.76.9.4350 10.1093/nar/gkp356 10.1056/NEJM200006293422606 10.1006/meth.2001.1261 10.1046/j.1365-2036.2000.014s1064.x 10.1006/niox.2001.0420 10.1007/s10555-011-9310-3 10.1016/j.biocel.2018.01.011 10.1038/bjc.2013.280 10.1186/s12906-016-1243-5 10.1146/annurev-nutr-071811-150726 10.1016/S0090-6980(02)00030-8 10.1016/j.yexcr.2006.03.027 10.1007/s004320000225 10.1093/jnci/djp440 10.5306/wjco.v5.i4.677 10.1016/j.cmet.2007.10.002 10.1016/j.canlet.2013.09.011 10.1126/science.1160809 10.1016/S0092-8674(02)00703-1 10.1024/0300-9831/a000064 10.1038/227680a0 10.1093/glycob/cwh025 10.1186/1471-2407-7-138 10.1186/1471-2407-9-267 10.1006/bbrc.1999.1840 10.1002/mrc.4094 10.1016/j.cell.2010.03.014 10.1186/s40170-015-0128-2 10.1038/nrc2618 10.1038/ncomms10558 10.3390/ijms141021167 10.1093/nar/gkv380 10.1002/ejlt.201100263 10.18632/oncotarget.19551 10.1006/excr.1999.4501 10.1016/j.prostaglandins.2011.08.004 10.1038/nrcardio.2010.121 10.1023/A:1015579209850 10.4103/0975-7406.199339 10.1111/j.1365-2273.1991.tb00975.x 10.4331/wjbc.v3.i8.167 10.1074/jbc.275.12.8461 10.1186/s12944-016-0225-4 |
ContentType | Journal Article |
Copyright | Copyright © 2018 Gautam, Rawat, Sammi, Roy, Singh, Devi, Yadav, Singh, Rawat, Ansari, Saeedan, Kumar, Pandey and Kaithwas. 2018 Gautam, Rawat, Sammi, Roy, Singh, Devi, Yadav, Singh, Rawat, Ansari, Saeedan, Kumar, Pandey and Kaithwas |
Copyright_xml | – notice: Copyright © 2018 Gautam, Rawat, Sammi, Roy, Singh, Devi, Yadav, Singh, Rawat, Ansari, Saeedan, Kumar, Pandey and Kaithwas. 2018 Gautam, Rawat, Sammi, Roy, Singh, Devi, Yadav, Singh, Rawat, Ansari, Saeedan, Kumar, Pandey and Kaithwas |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fphar.2018.00314 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1663-9812 |
ExternalDocumentID | oai_doaj_org_article_497bb025d28f42be86a2f0a46e27948c PMC5897656 29681851 10_3389_fphar_2018_00314 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-b03623515ae0c25bc255f1ad1f15fd9c7e23d3f0ccde177c8d221f0890c7580c3 |
IEDL.DBID | M48 |
ISSN | 1663-9812 |
IngestDate | Wed Aug 27 01:31:08 EDT 2025 Thu Aug 21 18:17:05 EDT 2025 Fri Jul 11 01:05:53 EDT 2025 Thu Apr 03 07:04:22 EDT 2025 Thu Apr 24 23:04:21 EDT 2025 Tue Jul 01 02:25:17 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | lipoxygenase NMR DuCLOX-2/5 inhibition angiogenesis apoptosis cyclooxygenase Zaltoprofen Zileuton |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-b03623515ae0c25bc255f1ad1f15fd9c7e23d3f0ccde177c8d221f0890c7580c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Anna Rita Migliaccio, Icahn School of Medicine at Mount Sinai, United States This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Pharmacology Reviewed by: Harikumar K.B., Rajiv Gandhi Centre for Biotechnology, India; Fabrizio Martelli, Istituto Superiore di Sanità, Italy |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2018.00314 |
PMID | 29681851 |
PQID | 2029631216 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_497bb025d28f42be86a2f0a46e27948c pubmedcentral_primary_oai_pubmedcentral_nih_gov_5897656 proquest_miscellaneous_2029631216 pubmed_primary_29681851 crossref_citationtrail_10_3389_fphar_2018_00314 crossref_primary_10_3389_fphar_2018_00314 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-04-06 |
PublicationDateYYYYMMDD | 2018-04-06 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-06 day: 06 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in pharmacology |
PublicationTitleAlternate | Front Pharmacol |
PublicationYear | 2018 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Laemmli (B34) 1970; 227 Rawat (B47); 5 Nie (B40) 2001; 20 Murray (B38) 2009; 9 Gautam (B16) 2018; 8 Kawai (B32) 2002; 68 Jobard (B27) 2014; 343 McIlwain (B37) 2013; 5 Wallace (B59) 2012; 12 Manral (B35) 2016; 16 Giulietti (B18) 2001; 25 Ghosh (B17) 2002; 109 Schneider (B53) 2011; 30 Cheung (B8) 2006; 312 EI-Hakim (B21) 1991; 16 Rani (B44) 2018; 183 Saldova (B52) 2007; 17 Zhuang (B66) 1999; 250 Ahn (B2) 2015; 3 Wishart (B60) 2007; 35 Greene (B19) 2011; 96 Harris (B24) 2014; 5 DeBerardinis (B9) 2008; 7 Xia (B62) 2015; 43 Belur (B4) 1990 Eberhart (B12) 1994; 107 Ewer (B13) 2010; 7 Joyce (B28) 2009; 9 Martinez (B36) 2004; 14 Rawat (B46); 8 Dempke (B10) 2001; 127 Kaithwas (B30) 2011; 49 Bratton (B6) 2010; 123 Zhang (B64) 2012; 3 Schutz (B55) 2011; 81 Qian (B42) 2010; 141 Ye (B63) 2005; 26 Kaithwas (B31) 2012; 114 Russo (B51) 1990 Xia (B61) 2009; 37 Ahmad (B1) 2009; 2 Flote (B14) 2016; 15 Rani (B43) 2016; 24 Roy (B49) 2017; 8 Dubois (B11) 2000; 14 Hammamieh (B22) 2007; 7 Jänne (B26) 2000; 342 Roy (B50) 2018; 96 Ristimäki (B48) 2002; 62 Guleria (B20) 2014; 52 Bustamante (B7) 2002; 6 Vander Heiden (B58) 2009; 324 Kumar (B33) 2016 Gautam (B15) 2016; 24 Schroeder (B54) 2007; 6 Kaithwas (B29) 2007; 3 Nie (B41) 2000; 267 Raphael (B45) 2013; 14 Zhang (B65) 2012; 32 Towbin (B57) 1979; 76 Newman (B39) 2017; 27 Steward (B56) 2013; 109 Benedict (B5) 2000; 275 Harris (B23) 2009; 17 Albini (B3) 2010; 102 Hartiala (B25) 2016; 7 |
References_xml | – volume: 27 start-page: 645 year: 2017 ident: B39 article-title: Serine and functional metabolites in Cancer publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2017.05.001 – volume: 183 start-page: 49 year: 2018 ident: B44 article-title: Effects of minocycline and doxycycline against terbutaline induced early postnatal autistic changes in albino rats publication-title: Physiol. Behav. doi: 10.1016/j.physbeh.2017.10.024 – volume: 26 start-page: 827 year: 2005 ident: B63 article-title: Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke publication-title: Carcinogenesis doi: 10.1093/carcin/bgi012 – volume: 62 start-page: 632 year: 2002 ident: B48 article-title: Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer publication-title: Cancer Res – volume: 5 start-page: a008656 year: 2013 ident: B37 article-title: Caspase functions in cell death and disease publication-title: Cold Spring Harbor Perspect. Biol doi: 10.1101/cshperspect.a008656 – volume: 35 start-page: D521 year: 2007 ident: B60 article-title: HMDB: the human metabolome database publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkl923 – volume: 17 start-page: 55 year: 2009 ident: B23 article-title: Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung publication-title: Inflammopharmacology doi: 10.1007/s10787-009-8049-8 – volume: 24 start-page: 180 year: 2016 ident: B15 article-title: DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention publication-title: Breast Cancer doi: 10.1007/s12282-016-0723-2 – volume: 24 start-page: 277 year: 2016 ident: B43 article-title: α-Chymotrypsin regulates free fatty acids and UCHL-1 to ameliorate N-methyl nitrosourea induced mammary gland carcinoma in albino wistar rats publication-title: Inflammopharmacology doi: 10.1007/s10787-016-0280-5 – volume: 8 start-page: 3512 year: 2018 ident: B16 article-title: Rifaximin, a pregnane X receptor (PXR) activator regulates apoptosis in a murine model of breast cancer publication-title: RSC Adv doi: 10.1039/C7RA09689E – volume: 5 start-page: 55 ident: B47 article-title: Serum metabolic disturbances hailing in initial hours of acute myocardial infarction elucidated by NMR based metabolomics publication-title: Curr. Metabolomics doi: 10.2174/2213235X04666160809123143 – volume: 17 start-page: 1344 year: 2007 ident: B52 article-title: Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG publication-title: Glycobiology doi: 10.1093/glycob/cwm100 – volume: 2 start-page: 495 year: 2009 ident: B1 article-title: An effective method for the analysis of human plasma proteome using two-dimensional gel electrophoresis publication-title: J. Proteomics Bioinform. doi: 10.4172/jpb.1000111 – volume: 123 start-page: 3209 year: 2010 ident: B6 article-title: Regulation of the Apaf-1– caspase-9 apoptosome publication-title: J. Cell Sci doi: 10.1242/jcs.073643 – volume: 107 start-page: 1183 year: 1994 ident: B12 article-title: Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas publication-title: Gastroenterol doi: 10.1016/0016-5085(94)90246-1 – volume: 12 start-page: 685 year: 2012 ident: B59 article-title: Mitochondria and cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3365 – volume: 76 start-page: 4350 year: 1979 ident: B57 article-title: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.76.9.4350 – volume: 37 start-page: W652 year: 2009 ident: B61 article-title: MetaboAnalyst: a web server for metabolomic data analysis and interpretation publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkp356 – volume: 342 start-page: 1960 year: 2000 ident: B26 article-title: Chemoprevention of colorectal cancer publication-title: N. Engl. J. Med doi: 10.1056/NEJM200006293422606 – volume: 25 start-page: 386 year: 2001 ident: B18 article-title: An overview of real-time quantitative PCR: applications to quantify cytokine gene expression publication-title: Methods doi: 10.1006/meth.2001.1261 – volume: 14 start-page: 64 year: 2000 ident: B11 article-title: Review article: cyclooxygenase–a target for colon cancer prevention publication-title: Aliment. Pharmacol. Ther doi: 10.1046/j.1365-2036.2000.014s1064.x – volume: 6 start-page: 183 year: 2007 ident: B54 article-title: Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines publication-title: J. Exp. Ther. Oncol – volume: 6 start-page: 333 year: 2002 ident: B7 article-title: Sequential NO production by mitochondria and endoplasmic reticulum during induced apoptosis publication-title: Nitric Oxide doi: 10.1006/niox.2001.0420 – volume: 30 start-page: 277 year: 2011 ident: B53 article-title: Cyclooxygenases and lipoxygenases in cancer publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-011-9310-3 – volume: 96 start-page: 51 year: 2018 ident: B50 article-title: GLA supplementation regulates PHD2 mediated hypoxia and mitochondrial apoptosis in DMBA induced mammary gland carcinoma publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2018.01.011 – volume: 109 start-page: 1 year: 2013 ident: B56 article-title: Cancer chemoprevention: a rapidly evolving field publication-title: Br. J. Cancer doi: 10.1038/bjc.2013.280 – volume: 16 start-page: 260 year: 2016 ident: B35 article-title: Effect of β-sitosterol against methyl nitrosourea-induced mammary gland carcinoma in albino rats publication-title: BMC Complement. Altern. Med doi: 10.1186/s12906-016-1243-5 – volume: 32 start-page: 203 year: 2012 ident: B65 article-title: Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids publication-title: Annu. Rev. Nutr. doi: 10.1146/annurev-nutr-071811-150726 – volume: 68 start-page: 187 year: 2002 ident: B32 article-title: Cyclooxygenases and colon cancer publication-title: Prostaglandins Other Lipid Mediat. doi: 10.1016/S0090-6980(02)00030-8 – volume: 312 start-page: 2347 year: 2006 ident: B8 article-title: Involvement of caspase-2 and caspase-9 in endoplasmic reticulum stress-induced apoptosis: a role for the IAPs publication-title: Exp. Cell Res doi: 10.1016/j.yexcr.2006.03.027 – volume: 127 start-page: 411 year: 2001 ident: B10 article-title: Cyclooxygenase-2: a novel target for cancer chemotherapy? publication-title: J. Cancer Res. Clin. Oncol doi: 10.1007/s004320000225 – volume: 102 start-page: 14 year: 2010 ident: B3 article-title: Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djp440 – volume: 5 start-page: 677 year: 2014 ident: B24 article-title: Cyclooxygenase-2 and the inflammogenesis of breast cancer publication-title: World J. Clin. Oncol doi: 10.5306/wjco.v5.i4.677 – volume: 7 start-page: 11 year: 2008 ident: B9 article-title: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation publication-title: Cell Metab. doi: 10.1016/j.cmet.2007.10.002 – volume: 343 start-page: 33 year: 2014 ident: B27 article-title: A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer publication-title: Cancer Lett. doi: 10.1016/j.canlet.2013.09.011 – volume: 324 start-page: 1029 year: 2009 ident: B58 article-title: Understanding the Warburg effect: the metabolic requirements of cell proliferation publication-title: Science doi: 10.1126/science.1160809 – volume: 109 start-page: S81 year: 2002 ident: B17 article-title: Missing pieces in the NF-κB puzzle publication-title: Cell doi: 10.1016/S0092-8674(02)00703-1 – start-page: 217 volume-title: Pathology Reviews year: 1990 ident: B51 article-title: Comparative study of human and rat mammary tumorigenesis – volume: 81 start-page: 101 year: 2011 ident: B55 article-title: Protein turnover, ureagenesis and gluconeogenesis publication-title: Int. J. Vitam. Nutr. Res. doi: 10.1024/0300-9831/a000064 – volume: 227 start-page: 680 year: 1970 ident: B34 article-title: Cleavage of structural proteins during the assembly of the head of bacteriophage T4 publication-title: Nature doi: 10.1038/227680a0 – volume: 14 start-page: 127 year: 2004 ident: B36 article-title: Galectin-1, a cell adhesion modulator, induces apoptosis of rat leyding cells in vitro publication-title: Glycobiol doi: 10.1093/glycob/cwh025 – volume: 7 start-page: 138 year: 2007 ident: B22 article-title: Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism publication-title: BMC Cancer doi: 10.1186/1471-2407-7-138 – volume: 9 start-page: 267 year: 2009 ident: B38 article-title: Histological analysis of low dose NMU effects in the rat mammary gland publication-title: BMC Cancer doi: 10.1186/1471-2407-9-267 – volume: 267 start-page: 245 year: 2000 ident: B41 article-title: Thromboxane A 2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis publication-title: Biochem. Biophys. Res. Commun doi: 10.1006/bbrc.1999.1840 – volume: 52 start-page: 475 year: 2014 ident: B20 article-title: Metabolite characterisation in peritoneal dialysis effluent using highâ resolution 1H and 1H-13C NMR spectroscopy publication-title: Magn. Reson. Chem. doi: 10.1002/mrc.4094 – start-page: 1 volume-title: Nuclear Magnetic Resonance Spectroscopy year: 2016 ident: B33 article-title: NMR based metabolomics: an emerging tool for therapeutic evaluation of traditional herbal medicines – volume: 141 start-page: 39 year: 2010 ident: B42 article-title: Macrophage diversity enhances tumor progression and metastasis publication-title: Cell doi: 10.1016/j.cell.2010.03.014 – volume: 3 start-page: 1 year: 2015 ident: B2 article-title: Mitochondria as biosynthetic factories for cancer proliferation publication-title: Cancer Metab. doi: 10.1186/s40170-015-0128-2 – volume: 9 start-page: 239 year: 2009 ident: B28 article-title: Microenvironmental regulation of metastasis publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2618 – volume: 7 start-page: 10558 year: 2016 ident: B25 article-title: Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease publication-title: Nat Commun. doi: 10.1038/ncomms10558 – volume-title: Laboratory Technology–A Procedure Manual for Routine Diagnostic Tests year: 1990 ident: B4 – volume: 14 start-page: 21167 year: 2013 ident: B45 article-title: Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms141021167 – volume: 43 start-page: W251 year: 2015 ident: B62 article-title: MetaboAnalyst 3.0– making metabolomics more meaningful publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkv380 – volume: 114 start-page: 1237 year: 2012 ident: B31 article-title: In vitro antioxidant and in vivo antidiabetic, antihyperlipidemic activity of linseed oil against streptozotocin-induced toxicity in albino rats publication-title: Eur. J. Lipid Sci. Technol doi: 10.1002/ejlt.201100263 – volume: 8 start-page: 70049 year: 2017 ident: B49 article-title: Alpha-linolenic acid stabilizes HIF-1 α and downregulates FASN to promote mitochondrial apoptosis for mammary gland chemoprevention publication-title: Oncotarget doi: 10.18632/oncotarget.19551 – volume: 250 start-page: 203 year: 1999 ident: B66 article-title: Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells publication-title: Exp. Cell Res. doi: 10.1006/excr.1999.4501 – volume: 96 start-page: 27 year: 2011 ident: B19 article-title: Regulation of inflammation in cancer by eicosanoids publication-title: Prostaglandins Other Lipid Mediat doi: 10.1016/j.prostaglandins.2011.08.004 – volume: 7 start-page: 564 year: 2010 ident: B13 article-title: Cardiotoxicity of anticancer treatments: what the cardiologist needs to know publication-title: Nat. Rev. Cardiol doi: 10.1038/nrcardio.2010.121 – volume: 3 start-page: 428 year: 2007 ident: B29 article-title: Reversal of sodium nitrite induced impairment of spontaneous alteration by Aloe vera gel: involvement of cholinergic system publication-title: Pharmacologyonline. – volume: 20 start-page: 195 year: 2001 ident: B40 article-title: Role of eicosanoids in prostate cancer progression publication-title: Cancer Metastasis Rev doi: 10.1023/A:1015579209850 – volume: 8 start-page: 327 ident: B46 article-title: 1H NMR-based serum metabolomics reveals erythromycin-induced liver toxicity in albino Wistar rats publication-title: J. Pharm. Bioallied Sci. doi: 10.4103/0975-7406.199339 – volume: 16 start-page: 563 year: 1991 ident: B21 article-title: Arachidonic acid cascade and oral squamous cell carcinoma publication-title: Clin. Otolaryngol doi: 10.1111/j.1365-2273.1991.tb00975.x – volume: 49 start-page: 260 year: 2011 ident: B30 article-title: Effect of aloe vera (Aloe barbadensis Miller) gel on doxorubicin-induced myocardial oxidative stress and calcium overload in albino rats publication-title: India J. Exp. Biol – volume: 3 start-page: 167 year: 2012 ident: B64 article-title: Dysregulated lipid metabolism in cancer publication-title: World J. Biol. Chem. doi: 10.4331/wjbc.v3.i8.167 – volume: 275 start-page: 8461 year: 2000 ident: B5 article-title: Expression and functional analysis of Apaf-1 isoforms extra WD-40 repeat is required for cytochrome cbinding and regulated activation of procaspase-9 publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.12.8461 – volume: 15 start-page: 56 year: 2016 ident: B14 article-title: Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer publication-title: Lipids Health Dis. doi: 10.1186/s12944-016-0225-4 |
SSID | ssj0000399364 |
Score | 2.2519205 |
Snippet | The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 314 |
SubjectTerms | angiogenesis apoptosis cyclooxygenase DuCLOX-2/5 inhibition lipoxygenase NMR Pharmacology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9tAEF5KTrmUtulDfbGFEihEWDtaraSjm0fTUrehJOCb2Cc2pLKp5UOgP74zK8WxS2kvPeiyWqFF8-3MN-zoG8beVsI7CFCnkNdFKkHr1JQ-pMpAUBVSDBM7z02-qPMr-WlaTLdafVFNWC8P3H-4kaxLYzAwO6iCBOMrpSFkWioPCKXKkvfFmLeVTEUfTHFXyf5cErOwehSWM036n4JqJ3Mhd-JQlOv_E8f8vVRyK_acPWD3B9LIx_1iH7J7vn3EDi961embI3559xPV6ogf8os7PeqbA_bzZH38-es0hVHBP7azuYlVWnzcIV1eE9XE0YDA-B4P3Pm3vmrWc906Tp090JPwCW58dJStI7zy8XKx7Bar-Yoj5eUTHf9_4x-oSJKTAgF1VhnqKB-zq7PTy-PzdGi6kFqpoEsNhbQcWY72mYXC4FUEoZ0IogiutqWH3OUhs9Z5UZa2cgAiZFWdWUw9Mps_YXvtovXPGM8VJlfIKDSJ4AjhdGYrr0pEQS7BQkjY6NYEjR0UyakxxnWDmQkZrYlGa8hoUcNUJuzd5ollr8bxl7nvyaqbeaSjHQcQXc2AruZf6ErYm1tMNLjv6DBFt36xXuGLAH2XAKES9rTHyOZVeId4kEhYuYOenbXs3mnns6jtXVTIDwv1_H8s_gXbp88R64zUS7bX_Vj7V0ihOvM67pZflWYb5g priority: 102 providerName: Directory of Open Access Journals |
Title | DuCLOX-2/5 Inhibition Attenuates Inflammatory Response and Induces Mitochondrial Apoptosis for Mammary Gland Chemoprevention |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29681851 https://www.proquest.com/docview/2029631216 https://pubmed.ncbi.nlm.nih.gov/PMC5897656 https://doaj.org/article/497bb025d28f42be86a2f0a46e27948c |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQeOEFAeMjfExGQpOQFho7iZM8TKhsjIEoTGiV-hb5k1YaSWlSaZX447lzspaiiice8hLHsuU73_0uPv-OkFc5s4Y7XoQ8LtIw4VKGKrMuFIo7kQPEUL7y3OiLOB8nnybpZHM9ul_AZmdoh_WkxourN9c_V29hwx9jxAn-duDmU4nUngzTImOsan0b_FKG9QxGPdj3dhl9sUi6s8qdHbd8k6fw34U7_06f_MMfnd0jd3sgSYed5O-TW7Z6QA4vOibq1RG93Fysao7oIb3YcFSv9smv0-XJ56-TkA9S-rGazpTP3KLDFiD0EuEnvHWgLD_8ITz91mXSWiorQ7HaB1gXOgJjAOtXGdRhOpzX87ZuZg0FGExH0t-Jox8wcZIiKwFWW-lzKx-S8dn7y5PzsC_EEOpE8DZU6OZiQD7SRpqnCp7UMWmYY6kzhc4sj03sIq2NZVmmc8M5c1FeRBrCkUjHj8heVVf2CaGxgIALUIZEYhzGjIx0bkUGmhEnXHMXkMGNCErds5RjsYyrEqIVFFrphVai0DyvaRKQ1-se846h4x_fvkOprr9Dbm3_ol58L_utWiZFphRAQcNzl3BlcyG5i2QiLAfjleuAvLzRiRL2Ih6wyMrWywYG4mDPGGciII87HVkPBS2IjVhAsi3t2ZrLdks1m3q-7zQHzJiKp_9j8s_IHVwOn3sknpO9drG0LwBWterA_4448HvmN45kJRQ |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DuCLOX-2%2F5+Inhibition+Attenuates+Inflammatory+Response+and+Induces+Mitochondrial+Apoptosis+for+Mammary+Gland+Chemoprevention&rft.jtitle=Frontiers+in+pharmacology&rft.au=Swetlana+Gautam&rft.au=Atul+K.+Rawat&rft.au=Shreesh+R.+Sammi&rft.au=Subhadeep+Roy&rft.date=2018-04-06&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=9&rft_id=info:doi/10.3389%2Ffphar.2018.00314&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_497bb025d28f42be86a2f0a46e27948c |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |